BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17124412)

  • 1. Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status.
    Jonkers YM; Claessen SM; Veltman JA; Geurts van Kessel A; Dinjens WN; Skogseid B; Ramaekers FC; Speel EJ
    Cytogenet Genome Res; 2006; 115(3-4):289-97. PubMed ID: 17124412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal instability predicts metastatic disease in patients with insulinomas.
    Jonkers YM; Claessen SM; Perren A; Schmid S; Komminoth P; Verhofstad AA; Hofland LJ; de Krijger RR; Slootweg PJ; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2005 Jun; 12(2):435-47. PubMed ID: 15947114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
    Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.
    Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P
    Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
    Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ
    J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.
    Speel EJ; Richter J; Moch H; Egenter C; Saremaslani P; Rütimann K; Zhao J; Barghorn A; Roth J; Heitz PU; Komminoth P
    Am J Pathol; 1999 Dec; 155(6):1787-94. PubMed ID: 10595906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serpin peptidase inhibitor clade A member 1 as a potential marker for malignancy in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; Krogh K; de Almeida MQ; Albergaria Pereira MA; Coelho Siqueira SA; Patzina RA; Ibuki FS; Sogayar MC; Machado MC; Giannella-Neto D
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5322-30. PubMed ID: 17855650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH.
    Lai LA; Paulson TG; Li X; Sanchez CA; Maley C; Odze RD; Reid BJ; Rabinovitch PS
    Genes Chromosomes Cancer; 2007 Jun; 46(6):532-42. PubMed ID: 17330261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
    Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
    Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
    La Rosa S; Rigoli E; Uccella S; Novario R; Capella C
    Histopathology; 2007 Apr; 50(5):597-606. PubMed ID: 17394496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple genetic alterations in malignant metastatic insulinomas.
    Pavelić K; Hrasćan R; Kapitanović S; Karapandza N; Vranes Z; Belicza M; Kruslin B; Cabrijan T
    J Pathol; 1995 Dec; 177(4):395-400. PubMed ID: 8568594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
    Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
    Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
    Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
    Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
    Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
    Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers.
    Gaasenbeek M; Howarth K; Rowan AJ; Gorman PA; Jones A; Chaplin T; Liu Y; Bicknell D; Davison EJ; Fiegler H; Carter NP; Roylance RR; Tomlinson IP
    Cancer Res; 2006 Apr; 66(7):3471-9. PubMed ID: 16585170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.